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technological innovation have to be taken. To reach this goal, the
paper takes a case-study approach, i.e. surgical ablation (SA)
performed in concomitance with cardiac surgery procedures.
METHODS: An observational, retrospective, multi-centre study
was carried out. Three hospitals were selected based upon the
volume of activity (i.e. >50 SA procedures/year). Patients
(N = 311) were enrolled during a 16-month period and recruited
if they met inclusion criteria. Health care resource consumption
was measured in detail through a bottom-up micro-costing
approach. RESULTS: Direct and full costs of SA and of the
concomitant cardiac surgery procedures were calculated per
patient by using a standard costing approach. Mean direct cost of
surgical interventions (SA and the concomitant procedures) is
€9093 (range: 6406–14,746). While there is a large homogeneity
among centres as to costs of SA (mean €1889), signiﬁcant differ-
ences (p < 0.05) emerge in costs of concomitant interventions
(mean €7204) mainly because of different organisational pat-
terns. CONCLUSIONS: Hospital managers are struggling to face
the tension between scarcity of resources and increasing health
care needs. Technological innovation opens new opportunities
for hospital activities and patients’ health that however need to
be assessed against its costs. Which cost (i.e. direct vs. full
costing) is to be considered in the decision-making process
however is still not clear. There is a tendency to consider full
costing of new procedures and to decide whether they are ﬁnan-
cially sustainable by contrasting it to the relevant DRG(s).
Nevertheless, it is here argued that ﬁrstly, direct costing better
illustrates the true economic value of the innovative procedures
and therefore should be primarily used, and secondly, ﬁnancial
hospital sustainability would need to be assessed based upon
hospitals’ case-mix and not in silos.
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OBJECTIVES: Drug therapy should be appropriately prescribed
and administered in order to efﬁcaciously prevent cardiovascu-
lar events. The study aim was to describe the prescriptions of
statins in terms of persistence and compliance with the purpose
of identiﬁng appropriate pharmaco-epidemiological indicators
close to clinical practice. METHODS: Statins (ATC C10AA)
prescriptions data were collected from administrative databases
in two Local Health Units (LHUs) in Northern Italy. Eligible
patients should have had at least one statin prescription in three
consecutive years (2004–2006). The adopted indicators for drug
utilization included: “Calendar Days (CD)”, calculated as the
difference between the last and the ﬁrst prescription dates in
each year; “PDD days (PDDd)”, calculated as the ratio between
total mg prescribed and the surrogated prescribed daily doses;
“DDD days (DDDd)”, calculated as the ratio between total mg
prescribed and the deﬁned daily dose. A Compliance to Therapy
Index (CTI) was calculated as the ratio between the total PDDd
and the CD: indexes were calculated for each patient and clas-
siﬁed in four compliance categories (25%, >25% & 50%,
50% & 75%, >75% & 100%). RESULTS: Indicators
showed an increase in statins use over the study period in terms
of both DDD and sPDD. Persistence to therapy for at least two
years was around 50% in both LHUs. PDDd was a more reli-
able measure of the daily dosage in comparison with DDDd,
which resulted in a coverage period longer than the CD. CTI
analysis showed a decrease in low compliance categories
(patients in the range 25%–50% decreased from 26% to 17%)
and a raise in the rate of compliant patients (from 48% to
57%). Single prescriptions increased from 1% to 5%. CON-
CLUSIONS: Although statins’ use is steadily growing, poor
patients’ persistence and adherence to therapy would need the
implementation of strategies to improve compliance with lipid
lowering medications.
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OBJECTIVES: Cardiovascular drugs account for 40% of total
outpatient drug utilization in the City of Zagreb. Among them,
utilization of the group of hypolipemics showed greatest rise
from 2001 to 2006. The aim of the study was to investigate
outpatient utilization of hypolipemics in the City of Zagreb
during the 2001–2006 period and to assess the quality of pre-
scribing these drugs in primary health care. METHODS: The
number of deﬁned daily doses (DDD) and DDD per 1000 Zagreb
inhabitants per day (DDD/1000/day) were calculated on the
basis of data on the number of packages of each individual
hypolipemic (C10) for each study year. Data on the rate of
hospitalization for the leading cardiovascular complications were
collected as indirect indicators of the quality of prescribing
statins. RESULTS: The utilization of hypolipemics was 33.03
DDD/1000/day in 2001 and 72.38 DDD/1000/day in 2006,
yielding an almost twofold rise. Two drugs, simvastatin and
atorvastatin, predominated in the utilization of statins with 93%.
From 2001 to 2006, the utilization of simvastatin showed a 30%
increase and that of atorvastatin more than sevenfold increase.
During the study period, the overall rate of hospitalization for
cardiovascular disorders decreased by 18.5%. CONCLUSIONS:
The decreasing tendency recorded in hospitalization for cardio-
vascular diseases points to the improved quality of secondary
prevention, including statins. The growing trend observed in the
utilization of atorvastatin vs. simvastatin is indicative of the still
inappropriate prescribing practice, whereas the high rate of hos-
pitalization for hypertension reﬂects inadequate primary preven-
tion of cardiovascular disorders.
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OBJECTIVES: This study examined the effect of Octylcyanoac-
rolate topical skin adhesive (DERMABOND Topical Skin
Adhesive) on the risk of surgical site infection (SSI) and other
clinical outcomes and resource utilization in patients undergo-
ing coronary artery bypass graft (CABG) surgery. METHODS:
This study utilized the Premier Perspective(tm) Comparative
Database, which includes over ﬁce million hospital discharges
per year. Qualifying patients who underwent CABG surgery
during 2005 and 2006 were identiﬁed. Patients were classiﬁed
into four groups by method of surgical wound closure (sutures
only; sutures/DERMABOND; sutures/staples; and sutures/
staples/DERMABOND). The primary study outcome was the
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